Claims for Patent: 9,074,003

Summary for Patent: 9,074,003

Title:	Methods of inhibiting activation of complement component C4 with anti-C1s antibodies
Abstract:	The present disclosure provides antibodies that bind complement C1s protein; and nucleic acid molecules that encode such antibodies. The present disclosure also provides compositions comprising such antibodies, and methods to produce and use such antibodies, nucleic acid molecules, and compositions.
Inventor(s):	Peter Van Vlasselaer, Graham Parry, Nancy E. Stagliano, Sandip Panicker
Assignee:	Bioverativ USA Inc
Application Number:	US14/152,684

Details for Patent 9,074,003

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Takeda Pharmaceuticals U.s.a., Inc.	VONVENDI	von willebrand factor (recombinant)	For Injection	125577	December 08, 2015	9,074,003	2034-01-10

International Patent Family for US Patent 9,074,003

Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2014071206
United States of America	9562092
United States of America	9206259
United States of America	9074004
United States of America	8945562
United States of America	8877197